FMC
16
-13
JBHT
66
-3
VLO
50
-5
CNP
52
2
BK
74
-5
ILMN
70
-4
CMI
72
-5
KR
32
2
DTE
38
-2
GOOGL
59
9
BA
42
4
ROK
60
-6
FFIV
54
-2
URI
46
-4
GILD
47
-5
NVDA
47
-5
BAX
50
2
AN
52
-13
HOG
35
-3
AVGO
38
-25
FMC
16
-13
JBHT
66
-3
VLO
50
-5
CNP
52
2
BK
74
-5
ILMN
70
-4
CMI
72
-5
KR
32
2
DTE
38
-2
GOOGL
59
9
BA
42
4
ROK
60
-6
FFIV
54
-2
URI
46
-4
GILD
47
-5
NVDA
47
-5
BAX
50
2
AN
52
-13
HOG
35
-3
AVGO
38
-25
Financhill
Back

Intuit, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Buy
65

INTU
Intuit, Inc.

Last Price:
$670.86
Seasonality Move:
1.16%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$54.70
Seasonality Move:
11.58%
Buy
65
Intuit, Inc. (INTU) is a Buy

Is Intuit, Inc. a Buy, Sell or Hold?

  • The current Intuit, Inc. [INTU] share price is $670.93. The Score for INTU is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • INTU is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

INTU Stock Price Chart

What is Intuit, Inc.'s stock price today?

  • The Intuit, Inc. share price today is $670.93
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INTU is experiencing slight selling pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

INTU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.41 Buy
Relative Strength Index (14 RSI): 56 Buy
Chaikin Money Flow: -842063 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (640.21 - 664.81) Buy
Bollinger Bands (100): (639.55 - 723.77) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

INTU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 663.22 Buy
20-day SMA: 652.34 Buy
50-day SMA: 657.96 Buy
200-day SMA: 678.1 Sell
8-day EMA: 662.63 Buy
20-day EMA: 657.06 Buy
50-day EMA: 661.84 Buy
200-day EMA: 670.97 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Intuit, Inc. Earnings Growth & INTU Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.79 per share, an increase next quarter of $0.42 per share, an increase this year of $3.26 per share, and an increase next year of $3.10 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Intuit, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):